Ph.D. in Clinical Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Ali Nouraeinejad, Ph.D. in Clinical Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran.
Received: May 22, 2021; Published: August 18, 2021
The prevalence of myopia and high myopia is rising worldwide at an alarming pace [1,2]. This is in an order or sequence of processes linked to significant increases in the risk of vision impairment from pathological conditions associated with high myopia, including retinal damage, cataract, and glaucoma [1,2].
Regrettably, the issue of vision impairment associated with myopia receives limited attention from a public health viewpoint in terms of assessment of prevalence, protective interventions, and possible treatment selections [1,2].
Citation: Ali Nouraeinejad. “The Myopia Impact".Acta Scientific Ophthalmology 4.9 (2021): 35-36.
Copyright: © 2021 Ali Nouraeinejad. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.